Loading...
ROCO
4107
Market cap252mUSD
Jul 09, Last price  
117.00TWD
1D
0.00%
1Q
-4.49%
Jan 2017
-1.68%
IPO
324.68%
Name

Bioteque Corp

Chart & Performance

D1W1MN
ROCO:4107 chart
P/E
15.04
P/S
3.80
EPS
7.78
Div Yield, %
4.27%
Shrs. gr., 5y
-0.08%
Rev. gr., 5y
1.86%
Revenues
2.14b
+3.03%
491,852,000560,061,000654,864,000780,014,000821,623,000760,314,000842,308,000957,883,0001,123,668,0001,259,420,0001,406,959,0001,420,219,0001,613,009,0001,858,900,0001,947,661,0001,825,491,0002,010,272,0001,944,701,0002,072,575,0002,135,451,000
Net income
539m
+2.07%
57,268,000309,149,000171,455,000158,516,000172,587,000128,597,000166,308,000215,224,000290,902,000315,766,000358,232,000303,939,000404,997,000464,172,000488,665,000431,257,000493,540,000452,550,000528,260,000539,185,000
CFO
657m
-6.52%
77,470,000159,768,000277,232,000174,323,000185,387,000148,434,000183,438,000270,440,000368,709,000385,428,000380,631,000336,514,000460,413,000623,411,000634,506,000469,246,000644,579,000679,375,000702,617,000656,835,000
Dividend
Jul 28, 20265.5 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in Taipei, Taiwan, in 1991, Bioteque Corporation operates as a global manufacturer and supplier of medical devices, serving markets across Asia, South America, North America, and other international regions. The company specializes in a diverse range of medical disposables, critical for applications such as hemodialysis access and endovascular treatments. Its comprehensive product line features dialysis equipment, including bloodlines, A.V.F. needles, and hemodialysis catheters; interventional radiology solutions like pigtail drainage catheter sets and introducer sets; and urology essentials such as ureteral stent sets and urine collection bags. Furthermore, Bioteque offers IV administration products, including PVC infusion bags and twist-off ports; respiratory care items like closed suction catheters and endotracheal tubes; and a suite of vascular access products, including angiographic catheters, PTA balloon dilatation catheters, and guidewires. The company also manufactures a wide array of specialized medical components, such as dialyzer connectors, various luer lock connectors, filters, clamps, and transducer protectors, alongside medical masks.
IPO date
Jan 02, 2002
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT